Theranexus (EPA:ALTHX) | WebDisclosure

Basculer en Français

10608	Companies
225190	Keywords
153850	Articles
119146	Press releases

Home
Companies
Theranexus

PRESS RELEASE

published on 09/25/2025 at 18:00, 8 months 26 days ago

THERANEXUS ANNOUNCES FIRST HALF 2025 FINANCIAL RESULTS
Theranexus announces first half 2025 financial results showing a decrease in operating expenses and a net loss of €1,072 K. Focus on developing flagship asset TX01 and advancing Batten-1

Financial Results Theranexus Batten-1 Operating Expenses TX01
BRIEF

published on 07/17/2025 at 18:05, 11 months 4 days ago

Bilan Semestriel du Contrat de Liquidité de Theranexus

Contrat De Liquidité PORTZAMPARC Bilan Financier Biopharmaceutique Theranexus
BRIEF

published on 07/17/2025 at 18:05, 11 months 4 days ago

Half-Yearly Review of the Theranexus Liquidity Contract

Liquidity Contract PORTZAMPARC Financial Statement Biopharmaceuticals Theranexus
PRESS RELEASE

published on 07/17/2025 at 18:00, 11 months 4 days ago

BILAN SEMESTRIEL DU CONTRAT DE LIQUIDITÉ CONFIÉ À PORTZAMPARC
Theranexus publie son bilan semestriel de contrat de liquidité confié à Portzamparc. Retraits, négociations de titres et information sur la société

Contrat De Liquidité PORTZAMPARC Biopharmaceutique Theranexus Neurologiques
BRIEF

published on 07/10/2025 at 18:05, 11 months 11 days ago

Theranexus Dévoile sa Position de Trésorerie au 30 Juin 2025

Trésorerie Theranexus Batten-1 Innovation Biopharmaceutique Maladies Neurologiques
BRIEF

published on 07/10/2025 at 18:05, 11 months 11 days ago

Theranexus Reveals its Cash Position as of June 30, 2025

Treasury Biopharmaceutical Innovation Theranexus Batten-1 Neurological Diseases
PRESS RELEASE

published on 07/10/2025 at 18:00, 11 months 11 days ago

THERANEXUS PUBLIE SA POSITION DE TRÉSORERIE AU 30 JUIN 2025
Theranexus communique sa trésorerie au 30 juin 2025. Récapitulant sa situation financière, la société biopharmaceutique met en avant ses projets innovants en neurologie

Innovation Trésorerie Theranexus Neurologie Rareté
PRESS RELEASE

published on 07/10/2025 at 18:00, 11 months 11 days ago

THERANEXUS PUBLISHES ITS CASH POSITION AS OF 30 JUNE 2025
Theranexus, a biopharmaceutical company, reports a cash position of €2.1M as of 30 June 2025, with upcoming funds and financial visibility through Q2 2026. CEO discusses collaborations and strategic progress. H1 2025 results expected on September 25, 2025

Cash Position Biopharmaceutical Financial Publication Theranexus Rare Neurological Diseases
BRIEF

published on 05/13/2025 at 18:05, 1 year 1 month ago

Theranexus et BBDF révèlent des résultats prometteurs pour le Batten-1

Theranexus Batten-1 Maladie De Batten BBDF Acuité Visuelle
BRIEF

published on 05/13/2025 at 18:05, 1 year 1 month ago

Theranexus and BBDF reveal promising results for Batten-1

Theranexus Batten-1 BBDF Batten Disease Visual Acuity

Accesswire

Published on 06/22/2026 at 14:01, 25 minutes ago

Worksport (NASDAQ:WKSP) Achieves 35% May Gross Margin, Lands Meyer Distribution, Targets $36M+ Revenue Run-Rate
Published on 06/22/2026 at 14:00, 26 minutes ago

Adcore Enters Strategic Partnership with TikTok as a Channel Sales Partner
Published on 06/22/2026 at 14:00, 26 minutes ago

Dateline Expands Music Valley HREE Project
Published on 06/22/2026 at 14:00, 26 minutes ago

Loop Industries Appoints Institutional Shareholder Jeff Geygan to Board; GVIC Outlines Intent to Increase Ownership Stake to 10%
Published on 06/22/2026 at 14:00, 26 minutes ago

TFS Financial Launches "Equipment Financing Powered by TFS" Program for WEX Customers

View all ACCESSWIRE

EQS Group

Published on 06/22/2026 at 14:00, 26 minutes ago

EQS introduces Q by EQS to bring AI-native intelligence to enterprise compliance programs
Published on 06/22/2026 at 14:00, 26 minutes ago

EQS dévoile « Q by EQS » pour intégrer l’intelligence artificielle native aux programmes de conformité des entreprises
Published on 06/22/2026 at 13:40, 46 minutes ago

Aroundtown SA: Release of a capital market information
Published on 06/22/2026 at 13:32, 53 minutes ago

EQS-Adhoc: Aumann increases price of share buyback offer to €17.80 per share
Published on 06/22/2026 at 12:36, 1 hour 49 minutes ago

Vienna Stock Exchange Admits SMRX Share of Emerald Horizon AG to Trading

Les Echos

Published on 06/22/2026 at 08:30, 5 hours 56 minutes ago

Eiffage entre en négociation exclusive avec Atlas Arteria en vue d’acquérir la concession du tunnel de Warnow à Rostock, en Allemagne
Published on 06/22/2026 at 08:30, 5 hours 56 minutes ago

Eiffage enters into exclusive negotiations with Atlas Arteria for the possible acquisition of the Warnow Tunnel concession in Rostock, Germany
Published on 06/19/2026 at 19:33, 2 days 18 hours ago

Déclaration hebdomadaire d'opérations effectuées du 15 au 19 juin 2026
Published on 06/19/2026 at 19:33, 2 days 18 hours ago

Disclosure of transactions in own shares from June 15 to June 19, 2026
Published on 06/19/2026 at 19:23, 2 days 19 hours ago

Imerys-06-2026-communique-capital-droits-de-vote-au-31-mai-2026

View all LES ECHOS COMFI WIRE